(Q74590768)
Statements
Combined epineurial therapy with neutralizing antibodies to tumor necrosis factor-alpha and interleukin-1 receptor has an additive effect in reducing neuropathic pain in mice (English)
C Sommer
M Schäfers
J Brinkhoff
S Neukirchen
1 September 2001